Sanofi Current Share Price | Sanofi Stock Screener
SANOFI
Pharmaceuticals
Sanofi Current Stock Price Today
Live Share Price NSE
₹3104.20
▼
-10.70 (-0.34%)
Live Share Price BSE
₹3104.45
▼
-11.70 (-0.38%)
As of September 9, 2026, the live Sanofi share price (NSE: SANOFI) is ₹3,104.20 on NSE and ₹3,104.45 on BSE, down 0.34% from the previous close, with shares trading between ₹3,100.00 and ₹3,124.90 in today's trading session, and a 52-week range of ₹3,097.10–₹5,080.00.
Browse SANOFI cash flow statement to support your investment research.
Use the Sanofi stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanofi Market Cap
₹7,273.53 Cr.
SANOFI P/E Ratio (TTM)
20.14
Sanofi P/B Ratio
8.56
EPS (TTM)
₹179.46
Dividend Yield
3.54%
Debt to Equity
0.02
SANOFI 52 Week High
₹5080.00
Sanofi 52 Week Low
₹3097.10
Operating Margin
32.00%
Profit Margin
22.26%
SANOFI Revenue (TTM)
₹539.00
EBITDA
₹175.00
Net Income
₹120.00
Total Assets
₹1,612.00
Total Equity
₹861.00
Sanofi Current Share Price Chart
Track the current Sanofi share price and stock price with an interactive chart. Analyse SANOFI price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sanofi stock quote in one place.
Sanofi Company Profile - Fundamental Screener
Screen Sanofi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANOFI shares.
Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Rahul Bhatnagar
ISIN
INE058A01010
Website
https://www.sanofiindialtd.com
Sanofi Balance Sheet Screener
Screen SANOFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 1,612 | 1,715 |
| Current Assets | 1,127 | 1,248 |
| Fixed Assets | 313 | 315 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 32 | 48 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 861 | 1,015 |
| Share Capital | 23 | 23 |
| Reserves & Surplus | 838 | 992 |
Sanofi Income Statement Screener - Profit & Revenue Analysis
Screen Sanofi income statement and profit fundamentals.
Analyze SANOFI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanofi share price evaluation.
| Item | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 539 | 579 | 503 | 526 | 529 | 622 | 572 | 573 | 547 |
| Expenses | 364 | 400 | 367 | 404 | 397 | 368 | 393 | 377 | 370 |
| EBITDA | 175 | 179 | 137 | 122 | 132 | 254 | 179 | 195 | 177 |
| Operating Profit % | 32.00% | 22.00% | 21.00% | 23.00% | 23.00% | 29.00% | 24.00% | 23.00% | 21.00% |
| Depreciation | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Profit Before Tax | 165 | 169 | 127 | 113 | 122 | 244 | 169 | 186 | 167 |
| Tax | 46 | 33 | 24 | 30 | 31 | 54 | 46 | 34 | 30 |
| Net Profit | 120 | 137 | 103 | 82 | 91 | 190 | 123 | 152 | 138 |
| EPS | 51.89 | 59.31 | 44.81 | 35.69 | 39.64 | 82.78 | 53.37 | 65.95 | 59.79 |
Sanofi Cash Flow Screener - Liquidity Fundamentals
Screen SANOFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | 462 | 230 |
| Investing Activities | -180 | 38 |
| Financing Activities | -392 | -878 |
| Net Cash Flow | -111 | -610 |
Sanofi Shareholding Pattern Screener
See Sanofi shareholding pattern with promoter, FII, and DII holdings.
Check Sanofi promoter holding and ownership changes for SANOFI on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% |
| FII Holding | 5.64% | 5.69% | 5.57% | 5.61% | 5.57% | 5.55% | 6.11% | 5.81% |
| DII Holding | 21.13% | 19.86% | 23.02% | 23.06% | 22.29% | 21.31% | 23.08% | 22.79% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.19% | 11.38% | 8.38% | 8.33% | 9.08% | 10.02% | 7.97% | 8.31% |
| Other Holding | 2.64% | 2.67% | 2.63% | 2.61% | 2.67% | 2.73% | 2.44% | 2.69% |
| Shareholder Count | 75,758 | 80,005 | 68,196 | 66,790 | 71,395 | 75,813 | 61,849 | 67,662 |
Sanofi Share Dividend Screener - Share Yield Analysis
Check Sanofi dividend history with payout and yield data.
View Sanofi dividend details including ex-dates and amounts for SANOFI stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹123.00 | 3.83% |
| 2024-March | ₹117.00 | 2.04% |
| 2023-March | ₹167.00 | 2.06% |
| 2022-March | ₹570.00 | 10.15% |
| 2021-March | ₹490.00 | 6.53% |
| 2020-March | ₹365.00 | 4.63% |
| 2019-March | ₹349.00 | 5.58% |
| 2018-March | ₹84.00 | 1.44% |
| 2017-March | ₹71.00 | 1.37% |
Sanofi Stock Index Membership
See which indices include Sanofi stock.
Check SANOFI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
Sanofi Market Events Screener - Corporate Actions
Get Sanofi corporate actions including splits, bonuses, and buybacks.
Check Sanofi stock events that may affect SANOFI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | -0.87% |
| 2026-04-29 | 2026-04-29 | Annual General Meeting | NA | 6.75% |
| 2026-04-28 | 2026-04-28 | Quarterly Result Announcement | NA | -3.56% |
| 2026-04-22 | 2026-04-22 | Dividend | ₹ 48.00 /share | -12.09% |
| 2026-02-25 | 2026-02-25 | Quarterly Result Announcement | NA | 1.76% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 75.00 /share | -0.04% |
| 2025-10-29 | 2025-10-29 | Quarterly Result Announcement | NA | -0.54% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -1.25% |
| 2025-05-15 | 2025-05-15 | Annual General Meeting | NA | 8.45% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | 3.05% |
| 2025-04-25 | 2025-04-25 | Dividend | ₹ 117.00 /share | 29.68% |
| 2025-02-27 | 2025-02-27 | Quarterly Result Announcement | NA | -5.46% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | -6.25% |
| 2024-05-14 | 2024-05-14 | Annual General Meeting | NA | -13.18% |
| 2024-05-03 | 2024-05-03 | Dividend | ₹ 117.00 /share | -5.75% |
Sanofi Competitors Screener - Peer Comparison
Screen SANOFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 455,634 | 37.70 | 61,674 | 12.69% | 11,565 | 44.62 |
| Divis Laboratories | 241,576 | 83.91 | 11,067 | 13.95% | 2,568 | 65.13 |
| Torrent Pharmaceuticals | 184,745 | 86.89 | 13,886 | 20.34% | 2,138 | 44.72 |
| Zydus Life Science | 112,698 | 24.65 | 27,658 | 17.64% | 5,026 | 45.48 |
| Cipla | 111,887 | 33.44 | 29,045 | 2.24% | 3,870 | 36.26 |
| Laurus Labs | 99,334 | 92.77 | 6,868 | 22.01% | 890 | 54.21 |
| Lupin | 96,476 | 17.59 | 29,039 | 26.75% | 5,356 | 25.94 |
| Mankind Pharma | 96,141 | 46.84 | 14,636 | 14.85% | 1,938 | 38.69 |
| Dr Reddys Laboratories | 96,070 | 30.28 | 35,059 | 3.90% | 4,158 | 38.91 |
| Aurobindo Pharma | 95,116 | 25.23 | 34,145 | 5.56% | 3,503 | 54.82 |
Sanofi Company Announcements - News Screener
Screen SANOFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-05 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Show Cause Notice From GST Authorities | - |
| 2026-08-13 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-11 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-04 | Intimation Under Regulation 30(5) Of The Listing Regulations | - |
| 2026-08-04 | Re-Constitution Of The Committees Of The Company | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-04 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026 | - |
| 2026-08-04 | Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026 | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-20 | Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026. | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |